Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 5.51 -0.05 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $8.73 | |||
| Open | $5.61 | 52 Week Low | $2.86 | |||
| Day High | $5.70 | P/E | N/A | |||
| Day Low | $5.43 | EPS | $-3.82 | |||
| Volume | 568,547 | |||||
